Cochrane David MD is categorized under Internal Medicine Doctors in Denver, CO and active since 1950.
Cochrane David MD was established in 1950, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact David Cochrane at the company’s single location by writing to 155 South Madison St # 210, Denver, Colorado CO 80209 or by phoning (303) 333-5456. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cochrane David MD |
| Contact Person: | David Cochrane |
| Address: | 155 South Madison St # 210, Denver, Colorado 80209 |
| Phone Number: | (303) 333-5456 |
| Website Address: | denverimgroup.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1950 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Cochrane David MD was started in 1950 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact David Cochrane for inquiries that concern Cochrane David MD by calling the company number (303) 333-5456, as your correspondence is most welcome. Additionally, the physical location of the single location of Cochrane David MD can be found at the coordinates 39.713905,-104.94624 as well as the street address 155 South Madison St # 210 in Denver, Colorado 80209.
For its online presence, you may visit Cochrane David MD’s website at denverimgroup.com and engage with its social media outlets through on Twitter and on Facebook.